Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles
出版年份 2018 全文链接
标题
Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles
作者
关键词
-
出版物
RSC Advances
Volume 8, Issue 20, Pages 11163-11176
出版商
Royal Society of Chemistry (RSC)
发表日期
2018-03-21
DOI
10.1039/c8ra00720a
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Treatment of pulmonary tuberculosis: past and present†
- (2017) Dmitry Borisovich Giller et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Tackling Drug-Resistant Tuberculosis: Current Trends and Approaches
- (2017) Rashmi Tandon et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Molecular Drug-Susceptibility Test for Tuberculosis
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- From the Viewpoint of Drug Metabolism Research
- (2017) Miki Nakajima YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents
- (2017) Kai Lv et al. ACS Medicinal Chemistry Letters
- DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization
- (2015) Miroslav Brecik et al. ACS Chemical Biology
- The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis
- (2015) Vadim Makarov et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening
- (2015) Ujjini H. Manjunatha et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Tuberculosis
- (2014) Yong-Soo Kwon et al. CURRENT OPINION IN PULMONARY MEDICINE
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- Pharmacokinetics-Pharmacodynamics Analysis of Bicyclic 4-Nitroimidazole Analogs in a Murine Model of Tuberculosis
- (2014) Suresh B. Lakshminarayana et al. PLoS One
- Tuberculosis: The drug development pipeline at a glance
- (2012) Baptiste Villemagne et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Antitubercular Benzothiazinone Compounds by Ligand-Based Design
- (2012) Tomislav Karoli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors
- (2012) S. M. Batt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacokinetic profile of SKP-1041, a modified release formulation of zaleplon
- (2011) David J. Greenblatt et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-β-d-ribose 2′-epimerase DprE1 ofMycobacterium tuberculosis
- (2010) Claudia Trefzer et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Ex vivo permeability experiments in excised rat intestinal tissue and in vitro solubility measurements in aspirated human intestinal fluids support age-dependent oral drug absorption
- (2009) Pieter Annaert et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started